MMSI · NASDAQ
Merit Medical Systems, Inc.
$93.40 -1.34 (-1.43%)
Company overview
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments: Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs, and cardiac intervention products including access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions including critical care products, disinfection protection systems, syringes, manifold kits, trays and packs, coated tubes and wires, and sensor components for microelectromechanical systems.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NASDAQ
- Market cap
- $5.6B
- Employees
- 7,400
- Headquarters
- South Jordan, UT
- Website
- merit.com
- CEO
- Martha Goldberg Aronson
- Listed
- May 14, 1990
- P/E
- 39.74
- Dividend yield
- 0.00%
Company financials
- Revenue
- $1.5B
- Gross profit
- $751M
- Operating income
- $187M
- EBITDA
- $323M
- Net income
- $139M
- EPS
- $2.35
- Total assets
- $2.7B
- Total debt
- $822M
- Gross margin
- 48.65%
- Net margin
- 9.03%
- Earnings yield
- 2.52%
Showing FY 2025
MMSI
1D
NASDAQ
O93.18H93.76L91.30C93.33+1.12 (+1.21%)Vol171.95K